|
||
|
Unimed Pharmaceuticals Incorporated
Download PDF Members: Unimed Pharmaceuticals Incorporated develops and markets prescription pharmaceutical products. Unimed Pharmaceuticals strategy is to establish a leading position within specialty pharmaceutical markets. Unimed Pharmaceuticals expects to build a diversified portfolio of products in several therapeutic areas including HIV and other infectious diseases, endocrinology, hematology, oncology and urology. Currently, the Unimed Pharmaceuticals promotes three approved drugs for these markets: Marinol(R) (dronabinol), an appetite stimulant and antiemetic drug, Maxaquin(R) (lomefloxacin), a fluoroquinolone anti-infective used in the urology and infectious disease markets, and Anadrol(R)(oxymetholone), an orally active anabolic androgenic steroid used to treat various anemias.
This page has been viewed 236 times since April 2007, the link to the organisation's website has been followed 0 times Recent Search Terms used to find this page: unimed | Unimed Pharmaceuticals | UNIMED PHAR | unimed portfolio | unimed | unimed pharmaceuticals | unimed pharmaceuticals, deerfield il | Unimed anabolics | unimed pharmaceuticals | Unimed Pharmaceuticals email | . Search for more companies in Buffalo Grove Search for more companies in IL This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Unimed Pharmaceuticals Incorporated | ||||||||||||||||||||||||||||||||||||||||||||||||||
|
|